No abstract available
MeSH terms
-
Antiparkinson Agents / therapeutic use
-
Body Mass Index
-
Brain / metabolism
-
Combined Modality Therapy
-
Dopamine / metabolism
-
Electric Stimulation Therapy / adverse effects*
-
Humans
-
Levodopa / therapeutic use
-
Malnutrition / metabolism
-
Obesity / complications*
-
Obesity / metabolism
-
Parkinson Disease / complications*
-
Parkinson Disease / metabolism
-
Parkinson Disease / therapy*
-
Receptors, Dopamine D2 / metabolism
-
Subthalamic Nucleus / surgery
Substances
-
Antiparkinson Agents
-
Receptors, Dopamine D2
-
Levodopa
-
Dopamine